CLASS III Drug recall · Reported 7 Sep 2022 · FDA Enforcement Report

Nighttime Sleep-Aid (doxylamine succinate HCl) tablets recalled

LNK International is recalling Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg blisters per, distributed nationwide in the US. The recall was initiated on 4 Aug 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesP121512, exp. date 08/2023; P122015, exp. date 09/2023; P122712, exp. date 11/2023; P123090, exp. date 12/2023; P123170, exp. date 12/2023; P124325, exp. date 03/2024; P124664, exp. date 03/2024; P125165, exp. date 05/2024; P125576, exp. date 06/2024; P125577, exp. date 06/2024; P127089, exp. date 10/2024; P127090, exp. date 10/2024; P127386, exp. date 11/2024; P128572, exp. date 01/2025; P128383, exp. date 01/2025; P129536, exp. date 04/2025
Quantity recalled257,064 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1472-2022
FDA event ID
90708
Recalling firm
LNK International, Hauppauge, NY
Classification
Class III
Status
Terminated
Recall initiated
4 Aug 2022
FDA classified
30 Aug 2022
Reported
7 Sep 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Aug 2022Recall initiated by company
30 Aug 2022Classified by FDA+26 days
7 Sep 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.

Product as listed by the FDA

Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per carton, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 34873 4.

Where it was distributed

Product was distributed to one retailer who may have further distributed the product to other distribution sites nationwide in the USA.

Nationwide

Stores named: CVS

Questions about this recall

Why was it recalled?

Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.

Which lots are affected?

P121512, exp. date 08/2023; P122015, exp. date 09/2023; P122712, exp. date 11/2023; P123090, exp. date 12/2023; P123170, exp. date 12/2023; P124325, exp. date 03/2024; P124664, exp. date 03/2024; P125165, exp. date 05/2024; P125576, exp. date 06/2024; P125577, exp. date 06/2024; P127089, exp. date 10/2024; P127090, exp. date 10/2024; P127386, exp. date 11/2024; P128572, exp. date 01/2025; P128383, exp. date 01/2025; P129536, exp. date 04/2025

Where was it sold?

Product was distributed to one retailer who may have further distributed the product to other distribution sites nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from LNK International

All 6